FCMI

Foresite Capital Management IV Portfolio holdings

AUM $124M
This Quarter Return
-5.31%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$679M
AUM Growth
+$679M
Cap. Flow
-$19.3M
Cap. Flow %
-2.84%
Top 10 Hldgs %
99.26%
Holding
14
New
1
Increased
1
Reduced
–
Closed
2

Top Buys

1
HLTH
Cue Health Inc. Common Stock
HLTH
$11.9M
2
TPST icon
Tempest Therapeutics
TPST
$14

Top Sells

1
RLAY icon
Relay Therapeutics
RLAY
$20.4M
2
CYTK icon
Cytokinetics
CYTK
$10.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$223M 32.78% 9,671,643 – –
LYEL icon
2
Lyell Immunopharma
LYEL
$213M
$197M 28.95% 13,282,181 – –
ACRS icon
3
Aclaris Therapeutics
ACRS
$209M
$61.2M 9.01% 3,399,034 – –
PHVS icon
4
Pharvaris
PHVS
$1.39B
$57.8M 8.52% 3,261,926 – –
QSI icon
5
Quantum-Si Incorporated
QSI
$227M
$37.2M 5.48% 4,463,619 – –
NRIX icon
6
Nurix Therapeutics
NRIX
$714M
$36.1M 5.32% 1,205,798 – –
KURA icon
7
Kura Oncology
KURA
$686M
$34.7M 5.1% 1,849,947 – –
HLTH
8
DELISTED
Cue Health Inc. Common Stock
HLTH
$11.9M 1.75% +1,006,089 New +$11.9M
OLMA icon
9
Olema Pharmaceuticals
OLMA
$375M
$9.43M 1.39% 342,030 – –
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$6.52M 0.96% 1,787,094 – –
TPST icon
11
Tempest Therapeutics
TPST
$44M
$2.75M 0.41% 190,213 +1 +0% +$14
DBTX
12
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.3M 0.34% 297,711 – –
CYTK icon
13
Cytokinetics
CYTK
$4.23B
– – -545,101 Closed -$10.8M
RLAY icon
14
Relay Therapeutics
RLAY
$619M
– – -556,380 Closed -$20.4M